Institutional Ownership Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR). We have compiled data on the 305 institutions that hold shares in the stock, with a total of 95.9 Million shares, which have been reported (via 13F filing form) to have a value of $2.01 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
15,683,206
shares
|
$312 Million
0.01% of portfolio
|
Q2 2024
Added 2.19%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
12,184,289
shares
|
$242 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.37%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
11,111,111
shares
|
$221 Million
3.04% of portfolio
|
Q4 2024
Added 25.0%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,016,227
shares
|
$120 Million
0.0% of portfolio
|
Q4 2024
Reduced 5.32%
|
|
|
Slate Path Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,232,000
shares
|
$104 Million
1.89% of portfolio
|
Q4 2024
Added 7.1%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,954,947
shares
|
$58.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.31%
|
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,901,681
shares
|
$57.7 Million
2.41% of portfolio
|
Q4 2024
Added 18.01%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,507,296
shares
|
$49.9 Million
0.03% of portfolio
|
Q4 2024
Reduced 29.86%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
2,054,364
shares
|
$40.9 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
2,020,426
shares
|
$40.2 Million
0.0% of portfolio
|
Q4 2024
Reduced 5.96%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,010,129
shares
|
$40 Million
0.01% of portfolio
|
Q4 2024
Reduced 6.69%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,626,513
shares
|
$32.4 Million
0.05% of portfolio
|
Q1 2024
Reduced 6.81%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,536,412
shares
|
$30.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.32%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,484,419
shares
|
$29.5 Million
0.0% of portfolio
|
Q4 2024
Added 11.38%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,305,329
shares
|
$26 Million
0.0% of portfolio
|
Q4 2024
Added 195.65%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,294,210
shares
|
$25.8 Million
0.0% of portfolio
|
Q4 2024
Added 1.67%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,017,720
shares
|
$20.3 Million
0.0% of portfolio
|
Q4 2024
Added 1.07%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
914,550
shares
|
$18.2 Million
0.01% of portfolio
|
Q4 2024
Added 41.66%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
840,174
shares
|
$16.7 Million
0.12% of portfolio
|
Q4 2024
Reduced 2.96%
|
|
|
Western Financial Corporation
|
Nov 03, 2022 Q3 2022 |
820,320
shares
|
$16.3 Million
18.96% of portfolio
|
Q2 2022
Added 0.0%
|
|
|
Western Financial Corp/Ca
San Diego, CA |
Jan 23, 2025 Q4 2024 |
820,239
shares
|
$16.3 Million
8.47% of portfolio
|
Q3 2023
Reduced 0.01%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
794,373
shares
|
$15.8 Million
0.04% of portfolio
|
Q4 2024
Added 281.34%
|
|
|
Aquilo Capital Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
707,589
shares
|
$14.1 Million
20.7% of portfolio
|
Q4 2024
Reduced 11.09%
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
656,256
shares
|
$13.1 Million
0.0% of portfolio
|
Q4 2024
Added 41.47%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
632,214
shares
|
$12.6 Million
0.08% of portfolio
|
Q4 2024
Added 63.07%
|